参考文献/References:
[1]冯凯,郑燕华,杨鹤鸣,等.SAA与脓毒症进程的相关性及其生物学意义[J].中华卫生应急电子杂志,2018,4(5):290-297. [2]De Buck M,Gouwy M,Wang JM,et al.Structure and Expression of Different Serum Amyloid A(SAA)Variants and their Concentration-Dependent Functions During Host Insults[J].Curr Med Chem,2016,23(17):1725-1755. [3]Shouw L.Correlation analysis of serum amyloid A,heparin binding protein and the severity of sepsis[J].China Modern Medcine,2018,25(15):127-129. [4]贺小红,王莉敏.SAA、CRP、PCT联合检测诊断小儿急性期感染的价值[J].深圳中西医结合杂志,2020,30(20):83-84. [5]姜友珍,李爽,侯德风,等.降钙素原、C反应蛋白、白细胞计数联合检测在ICU医院获得性细菌性肺炎鉴别诊断中的价值[J].检验医学,2016,31(6):453-457. [6]Yang XJ,Zhao XQ,Shui WY,et al.Effect of ulinastatin combined with continuous blood purification on serum levels of LAC,PCT,CRP,and rehabilitation in ICU patients with sepsis[J].International Medicine and Health Guidance News,2018,24(1):80-84. [7]王翔,向小卫.持续血液净化联合乌司他丁对急性呼吸窘迫综合征患者血管内皮通透性指标和血清炎性因子的影响[J].临床误诊误治,2018,31(11):21-25. [8]陈巧霞.血清PCT与CRP对CAP并发脓毒症患者的病情及预后评估作用[J].临床肺科杂志,2018,23(12):2222-2225. [9]霍俊明,霍锐,胡玲,等.降钙素原,超敏C反应蛋白,胰石蛋白联合检测对脓毒症患儿预后的预测价值[J].四川大学学报(医学版),2017,48(3):422-426. [10]王焕焕,孙建荣,刘文林.脓毒症患者血清中内皮糖蛋白和肝素结合性表皮生长因子表达水平及其临床价值[J].内科急危重症杂志,2020,26(6):494-496. [11]李爱光,周康,孙孟良,等.血清PCT及D-D检测在急诊脓毒症患者病情以及预后的评估中的价值[J].临床肺科杂志,2018,23(5):828-831. [12]Singer M,Deutschman CS,Seymour CW,et al.The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)[J].JAMA,2016,315(8):801-810. [13]银雪,杨敬平,孙德俊,等.血浆游离cf-DNA定量分析在脓毒症患者诊断中的临床价值[J].中华肺部疾病杂志,2016,9(6):631-635. [14]孟强,屈峰,董伟,等.外周血游离DNA/NETs在脓毒症诊断和预后评估中的应用价值[J].中国呼吸与危重监护杂志,2018,17(3):255-258. [15]黄天宝,杨志燕,陈少剑,等.血浆游离DNA对脓毒症预后的预测价值[J].中华危重病急救医学,2018,30(10):925-928. [16]Stawski R,Walczak K,Perdas E,et al.Increased Circulating H3 Histone in Response to Repeated Bouts of Exercise Does Not Associate with Parallel Alterations of Cell-Free DNA[J].Biology,2021,10(3):181. [17]易梦秋,余旻.脓毒症导致多器官功能障碍的发病机制[J].实用医学杂志,2016,32(20):3451-3454. [18]隋欣烔,刘伟,刘晓伟,等.lncRNA PACER在脓毒症急性肺损伤中的表达水平及相关作用机制研究[J].临床和实验医学杂志,2020,19(11):1149-1153. [19]徐巍,陈志冬,唐坎凯,等.LncRNA-HOTAIR对脓毒症疾病的临床诊断价值[J].现代实用医学,2020,32(3):371-372,374. [20]李彦,叶璐.干扰长链非编码RNA TUG1上调miR-26a缓解LPS诱导的脓毒症大鼠线粒体损伤和免疫紊乱[J].免疫学杂志,2020,36(2):125-131. [21]崔敏萱,王文文,向安.等线粒体来源肽MOTS-c通过抑制促炎性因子分泌改善脓毒症小鼠生存率[J].现代生物医学进展,2019,19(15):2839-2844. [22]Li H,Ren K,Jiang T,et al.MOTS-c attenuates endothelial dysfunction via suppressing the MAPK/NF-κB pathway[J].Int J Cardiol,2018(268):40. [23]He G,Zhang X,Chen Y,et al.Isoalantolactone inhibits LPS-induced inflammation via NF-κB inactivation in peritoneal macrophages and improves survival in sepsis[J].Biomed Pharmacother,2017(90):598-607. [24]丁烨,戴璐,向雅婷,等.程序性死亡蛋白1(PD-1)及其配体PD-L1在脓毒症免疫细胞功能障碍中的作用及其应用[J].细胞与分子免疫学杂志,2020,36(9):843-848. [25]刘敏龙,赵玉杰,陈海燕,等.脓毒症患者外周血单核细胞PD-L1/PD-1表达及临床意义[J].山西医科大学学报,2016,47(6):526-530.
相似文献/References:
[1]温占兵.血管生成素-1水平变化预测脓毒症急性肺损伤的价值[J].医学信息,2018,31(13):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
WEN Zhan-bing.The Value of Angiopoietin-1 Level Change in Predicting Acute Lung Injury in Sepsis[J].Medical Information,2018,31(14):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
[2]申 贵,彭 翔,秦光梅.抗感染督导治疗对脓毒症患者预后影响的研究[J].医学信息,2019,32(01):82.[doi:10.3969/j.issn.1006-1959.2019.01.026]
SHEN Gui,PENG Xiang,QIN Guang-mei.Study on the Effect of Anti-infective Supervision on the Prognosis of Patients with Sepsis[J].Medical Information,2019,32(14):82.[doi:10.3969/j.issn.1006-1959.2019.01.026]
[3]张恺悦,陈幼琼.乌司他丁联合血必净对烧伤后脓毒症患者凝血功能及全身炎性反应的影响研究[J].医学信息,2019,32(04):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
ZHANG Kai-yue,CHEN You-qiong.Effect of Ulinastatin Combined with Xuebijing on Coagulation Function and Systemic Inflammatory Response in Patients with Sepsis after Burn[J].Medical Information,2019,32(14):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
[4]张文旭,徐 绸.红细胞宽度对脓毒症患者病情诊断及预后评估的价值[J].医学信息,2022,35(14):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
ZHANG Wen-xu,XU Chou.The Value of Red-blood-cell Distribution Width in the Diagnosis and Prognosis of Patients with Sepsis[J].Medical Information,2022,35(14):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
[5]朱思哲,叶成林.基于生物信息学分析构建免疫相关基因脓毒症预后模型[J].医学信息,2022,35(15):1.[doi:10.3969/j.issn.1006-1959.2022.15.001]
ZHU Si-zhe,YE Cheng-lin.Identification of Immune-related Gene Prognostic Model for Sepsis Based on Bioinformatics Analysis[J].Medical Information,2022,35(14):1.[doi:10.3969/j.issn.1006-1959.2022.15.001]
[6]杨勋能.参苓白术散对脓毒症患者肠道功能的影响[J].医学信息,2019,32(16):146.[doi:10.3969/j.issn.1006-1959.2019.16.049]
YANG Xun-neng.Effect of Shenling Baizhu Powder on Intestinal Function in Patients with Sepsis[J].Medical Information,2019,32(14):146.[doi:10.3969/j.issn.1006-1959.2019.16.049]
[7]杜金洁,胡 鹏.ESKAPE病原菌感染引起脓毒症的研究[J].医学信息,2019,32(21):33.[doi:10.3969/j.issn.1006-1959.2019.21.012]
DU Jin-jie,HU Peng.Study on Sepsis Caused by ESKAPE Pathogen Infection[J].Medical Information,2019,32(14):33.[doi:10.3969/j.issn.1006-1959.2019.21.012]
[8]刘安平,段海真,汪 松.抗菌肽LL-37的生物学活性及其作用[J].医学信息,2019,32(24):13.[doi:10.3969/j.issn.1006-1959.2019.24.005]
LIU An-ping,DUAN Hai-zhen,WANG Song.Biological Activity and Effect of Antibacterial Peptide LL-37[J].Medical Information,2019,32(14):13.[doi:10.3969/j.issn.1006-1959.2019.24.005]
[9]陈冀远.右美托咪啶对脓毒症急性肾损伤患者肾功能及血管紧张素Ⅱ表达的影响[J].医学信息,2020,33(01):142.[doi:10.3969/j.issn.1006-1959.2020.01.045]
CHEN Ji-yuan.Effect of Dexmedetomidine on Renal Function and Angiotensin Ⅱ Expression in Patients with Acute Renal Injury in Sepsis[J].Medical Information,2020,33(14):142.[doi:10.3969/j.issn.1006-1959.2020.01.045]
[10]赵振宇.miR-33表达与炎症反应的关系[J].医学信息,2020,33(02):73.[doi:10.3969/j.issn.1006-1959.2020.02.020]
ZHAO Zhen-yu.Relationship Between miR-33 Expression and Inflammatory Response[J].Medical Information,2020,33(14):73.[doi:10.3969/j.issn.1006-1959.2020.02.020]